Lilly For Patients ALIMTA® (pemetrexed for injection) CYRAMZA® (ramucirumab) ERBITUX® (cetuximab) Portrazza® (necitumumab) Retevmo® (selpercatinib) Verzenio Continuous Care™ Support Program For Healthcare Providers Contact Us This website uses cookies and other technologies to personalize content and ads on this and other websites and provide social media features. By clicking “I Agree” you consent to our use of tracking technologies and disclosure of tracking data to third party ad networks or social media companies for the purposes above. If you click "I Disagree" you can still use this website. For more information about Lilly’s privacy practice and to manage third-party preferences, click here. I Disagree I Agree Welcome to the Lilly Oncology Support Center Lilly Oncology is committed to helping you receive the care you need Lilly is dedicated to developing treatments, but we're more than just our medicines. We’re determined to do our part to help patients and their loved ones. We understand that facing the cost of cancer treatment can be difficult. Through the Lilly Oncology Support Center, we strive to offer individualized treatment support for eligible patients prescribed Lilly's product for their cancer treatment. For those who qualify, we can help with: Understanding your insurance coverage Review of financial-assistance options, including savings card programs and independent patient-assistance foundations For some products we provide dedicated, personalized support through every step of treatment. On the following pages, you'll find information on savings card programs and additional resources. These resources may help with financial challenges that some patients experience to get the Lilly medication that they need. Choose a product: ALIMTA® (pemetrexed for injection) CYRAMZA® (ramucirumab) ERBITUX® (cetuximab) Portrazza® (necitumumab) Retevmo® (selpercatinib) Verzenio® (abemaciclib) Prescribing Information for ALIMTA® (pemetrexed for injection) Patient Prescribing Information for ALIMTA® (pemetrexed for injection) Prescribing Information for CYRAMZA® (ramucirumab) Prescribing Information for ERBITUX® (cetuximab), including BOXED WARNING Prescribing Information for Portrazza® (necitumumab), including BOXED WARNING Prescribing Information for Retevmo® (selpercatinib) Patient Prescribing Information for Retevmo® (selpercatinib) Prescribing Information for Verzenio® (abemaciclib) Patient Prescribing Information for Verzenio® (abemaciclib) To speak to customer support: Call 1-866-472-8663 Monday - Friday, 8am — 10pm ET This site is intended for US residents ages 18 and over. PP-OC-US-0369 10/2021 ©Lilly USA, LLC 2021. All rights reserved. ALIMTA®, CYRAMZA®, ERBITUX®, Portrazza®, Retevmo®, and Verzenio® are registered trademarks and Verzenio Continuous Care™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. Other product/company names mentioned herein are the property of their respective owners. Terms of UsePrivacy StatementAccessibility StatementSitemap